At the biochemical level, Alzheimer’s disease is characterized by accumulation of insoluble forms of beta-amyloid (Aβ) and hyperphosphorylated tau protein (P-tau). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.